Compare CIVB & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CIVB | NPCE |
|---|---|---|
| Founded | 1884 | 1997 |
| Country | United States | United States |
| Employees | 535 | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 558.0M | 536.6M |
| IPO Year | 2012 | 2021 |
| Metric | CIVB | NPCE |
|---|---|---|
| Price | $27.42 | $15.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $26.60 | $18.33 |
| AVG Volume (30 Days) | 84.2K | ★ 124.4K |
| Earning Date | 04-22-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.90% | N/A |
| EPS Growth | ★ 31.34 | 29.03 |
| EPS | ★ 0.72 | N/A |
| Revenue | $19,023,000.00 | ★ $99,986,000.00 |
| Revenue This Year | $14.88 | $0.90 |
| Revenue Next Year | $5.99 | $24.46 |
| P/E Ratio | $37.25 | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $18.95 | $7.56 |
| 52 Week High | $27.48 | $19.60 |
| Indicator | CIVB | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 65.12 | 50.60 |
| Support Level | $21.39 | $15.40 |
| Resistance Level | $27.48 | $17.37 |
| Average True Range (ATR) | 0.62 | 0.73 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 96.99 | 50.71 |
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agricultural, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. The majority of its revenues are derived from the interest and fees gained on loans.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.